Bordetella sp. Versus Microbiota
博德特氏菌属
基本信息
- 批准号:8896095
- 负责人:
- 金额:$ 37.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal DiseasesAnimal ModelAnimalsAntibiotic TherapyAntibioticsBacteriaBehaviorBiological AssayBiological ModelsBiologyBordetellaBordetella pertussisCharacteristicsCommunicable DiseasesComplexControlled StudyDataDiseaseDistantDoseEmployee StrikesEvolutionFailureGenesGeneticGenomeGenomicsHealthHumanImmuneIn VitroIndividualInfectionInvadedLaboratory AnimalsLaboratory InfectionLibrariesLigandsLightLocationMeasuresMediatingMicrobeModelingMolecularMusMutationNasal cavityNatureNoseOrganismOutcomePathologyPatternPertussisPredispositionProcessRespiratory SystemRespiratory tract structureRoleSpecific qualifier valueSpecificitySystemTestingTranslatingUpper respiratory tractVirulence FactorsWorkbasebody systemhuman diseaseimprovedin vivomicrobial communitymicrobiomemicroorganismmutantnovel strategiespathogenpositional cloningpreventreceptorresearch studyrespiratorysuccesstooltransmission processweapons
项目摘要
DESCRIPTION (provided by applicant): Although the interactions between invading pathogens and the host's resident microbiota are clearly important to the outcome of many infections, they remain poorly understood with few experimental systems in which they can be explored at a molecular mechanistic level. We have recently identified striking differences between closely related pathogens of the genus Bordetella in their interactions with host microbiome that can explain important aspects of their biology, including host specificity and pathology. B. bronchiseptica efficiently colonizes the upper respiratory tracts (URT) of mice (ID50<10cfu) and displaces the resident microflora in the process. B. pertussis, which causes highly contagious Whooping Cough in humans, poorly colonizes mice (ID50>1000cfu) and does not affect resident microbiota. Testing the hypothesis that resident microbiota of mice inhibit colonization, we observed that clearing the URT of bacteria allows B. pertussis to efficiently colonize (ID50<100). We have now extended this work by identifying specific microorganisms that can prevent B. pertussis colonization. This application will 1. Define the ability of resident
microorganism(s) to inhibit B. pertussis colonization of mice, 2. Identify ecological mechanisms of competition amongst nasal microbiota and invading bordetellae, and 3. Determine the molecular mechanisms by which B. bronchiseptica clears microflora from the URT. This exceptionally powerful and tractable experimental system will allow us to study the complex interactions between invading pathogen and host resident microbiota to satisfying molecular mechanisms. Improved understanding of these interactions is likely to inform views of the many other mucosal pathogens for which there is not such a powerful host infection experimental system.
描述(由申请人提供):尽管入侵病原体与宿主居民微生物群之间的相互作用显然对许多感染的结果很重要,但由于很少有实验系统可以在分子机械水平上探索它们,但它们仍然对它们保持不足。我们最近确定了Bordetella属密切相关的病原体与宿主微生物组的相互作用之间的显着差异,这些病原体可以解释其生物学的重要方面,包括宿主特异性和病理。 B.支气管肽有效地在小鼠(ID50 <10CFU)的上呼吸道(URT)中定居,并在此过程中置换了居民的微生物。 B.百日咳在人类中引起高度传染性的百日咳,在小鼠(ID50> 1000cfu)上殖民不良,不影响常驻的微生物群。测试了小鼠居民菌群抑制定殖的假设,我们观察到清除细菌的urt允许百日咳芽孢杆菌有效地定殖(ID50 <100)。现在,我们通过确定可以防止百日咳芽孢杆菌定殖的特定微生物来扩展这项工作。此应用程序将1。定义居民的能力
微生物抑制小鼠的百日咳芽孢杆菌定植,2。识别鼻菌群中竞争的生态机制和入侵的bordetelae,以及3。确定支气管链球菌从urt中清除微氯的分子机制。这个异常强大且易于处理的实验系统将使我们能够研究入侵病原体和宿主居民微生物群以满足分子机制之间的复杂相互作用。对这些相互作用的理解的提高可能会为没有如此强大的宿主感染实验系统的许多其他粘膜病原体提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric T Harvill其他文献
Eric T Harvill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric T Harvill', 18)}}的其他基金
An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia
研究百日咳博德特氏菌与呼吸道上皮细胞相互作用的气液界面系统
- 批准号:
10665943 - 财政年份:2023
- 资助金额:
$ 37.68万 - 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
- 批准号:
10375566 - 财政年份:2021
- 资助金额:
$ 37.68万 - 项目类别:
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis
无细胞疫苗是否会导致缺乏百日咳博德特氏菌的增加
- 批准号:
10364771 - 财政年份:2021
- 资助金额:
$ 37.68万 - 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
- 批准号:
10194677 - 财政年份:2021
- 资助金额:
$ 37.68万 - 项目类别:
In vivo vaccine-driven evolution in Bordetella pertussis
百日咳博德特氏菌体内疫苗驱动的进化
- 批准号:
8986495 - 财政年份:2015
- 资助金额:
$ 37.68万 - 项目类别:
Systematic evaluation of B. pertussis ACT’s role as a protective antigen
百日咳博德特氏菌 ACT 作为保护性抗原的作用的系统评估
- 批准号:
9056231 - 财政年份:2015
- 资助金额:
$ 37.68万 - 项目类别:
Evolution of the Bordetellae from Commensals to Pathogens
博德特氏菌从共生菌到病原体的进化
- 批准号:
7886472 - 财政年份:2009
- 资助金额:
$ 37.68万 - 项目类别:
相似国自然基金
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
冠状动脉微血管疾病大动物模型中关键分子和心肌血流超声显像新技术研究
- 批准号:
- 批准年份:2020
- 资助金额:297 万元
- 项目类别:重点项目
视神经脊髓炎谱系疾病非人灵长类动物模型构建及表型评价
- 批准号:82071341
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
mTOR信号通路在耳蜗毛细胞发育和存活中的调控作用及其机制研究
- 批准号:81900937
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
糖脂代谢紊乱疾病灵长类动物模型构建与DNA/RNA编辑介导的基因治疗方法开发
- 批准号:91957122
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
相似海外基金
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
- 批准号:
10556087 - 财政年份:2023
- 资助金额:
$ 37.68万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 37.68万 - 项目类别:
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
靶向 CCR6-CCL20 通路治疗银屑病关节和附着点炎症
- 批准号:
10699251 - 财政年份:2023
- 资助金额:
$ 37.68万 - 项目类别:
Targeting Myosin to Treat Polycystic Kidney Disease
靶向肌球蛋白治疗多囊肾
- 批准号:
10699859 - 财政年份:2023
- 资助金额:
$ 37.68万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 37.68万 - 项目类别: